|
|
|
|
|
非在研适应症- |
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
A Randomized, Open-label, Single-dose, Crossover Study to Compare Pharmacokinetics of PRIC and Pranlukast Dry Syrup in Healthy Male Volunteers
The purpose of this study is Safety, Pharmacokinetic Study of PRIC
Phase III Clinical Trials to Assess the Efficacy and Safety of HLIM for Symptomatic Relief of Cough and Sputum in Patients With Acute Upper Respiratory Tract Infection or Acute Bronchitis
The purpose of this study is to assess the efficacy and safety of HLIM
Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients
Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients
100 项与 SAMA Pharma Co. Ltd. 相关的临床结果
0 项与 SAMA Pharma Co. Ltd. 相关的专利(医药)
100 项与 SAMA Pharma Co. Ltd. 相关的药物交易
100 项与 SAMA Pharma Co. Ltd. 相关的转化医学